HIDRADENITIS SUPPURATIVA (HS)
Clinical trials for HIDRADENITIS SUPPURATIVA (HS) explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA (HS) trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA (HS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Botox trial for chronic skin disease withdrawn before starting
Disease control TerminatedThis study aimed to test whether Botox injections could help control hidradenitis suppurativa, a painful skin condition that causes recurring abscesses and nodules. The trial planned to enroll people with active underarm lesions to see if Botox could reduce the number and severit…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE4 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Major trial tests Long-Term safety of promising skin disease drug
Disease control OngoingThis study follows 617 people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition, to check the long-term safety and effectiveness of the drug povorcitinib. Participants have already completed 54 weeks of treatment in previous studies and will continue…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC